Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease
We evaluated short-term response endpoints for acute graft-versus-host disease treatment trials. We postulated that response endpoints should correlate with reduced symptom burden and decreased subsequent treatment failure, defined as non-relapse mortality, recurrent malignancy, or additional system...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2014-02-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/6941 |